Detalhe da pesquisa
1.
Evaluating gene expression profiling by quantitative polymerase chain reaction to develop a clinically feasible test for outcome prediction in multiple myeloma.
Br J Haematol
; 163(2): 223-34, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23952215
2.
The use of CD138 positively selected marrow samples increases the applicability of minimal residual disease assessment by PCR in patients with multiple myeloma.
Ann Hematol
; 92(1): 97-100, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22956183
3.
Role of Intracellular Drug Disposition in the Response of Acute Myeloid Leukemia to Cytarabine and Idarubicin Induction Chemotherapy.
Cancers (Basel)
; 15(12)2023 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37370755
4.
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group.
Blood Cancer J
; 13(1): 77, 2023 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37173322
5.
Kappa deleting element as an alternative molecular target for minimal residual disease assessment by real-time quantitative PCR in patients with multiple myeloma.
Eur J Haematol
; 89(4): 328-35, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22805350
6.
Characteristics and Outcomes of Adult Patients in the PETHEMA Registry with Relapsed or Refractory FLT3-ITD Mutation-Positive Acute Myeloid Leukemia.
Cancers (Basel)
; 14(11)2022 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35681796
7.
Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia.
Blood
; 114(1): 148-52, 2009 Jul 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-19398719
8.
Upregulation of Dicer is more frequent in monoclonal gammopathies of undetermined significance than in multiple myeloma patients and is associated with longer survival in symptomatic myeloma patients.
Haematologica
; 96(3): 468-71, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21160068
9.
Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis.
Blood
; 112(7): 2709-12, 2008 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18594024
10.
BAALC is an important predictor of refractoriness to chemotherapy and poor survival in intermediate-risk acute myeloid leukemia (AML).
Ann Hematol
; 89(5): 453-8, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19943049
11.
Clinical significance of complex karyotype at diagnosis in pediatric and adult patients with de novo acute promyelocytic leukemia treated with ATRA and chemotherapy.
Leuk Lymphoma
; 60(5): 1146-1155, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30526152
12.
Baseline immunophenotypic profile of bone marrow leukemia cells in acute myeloid leukemia with nucleophosmin-1 gene mutation: a EuroFlow study.
Blood Cancer J
; 13(1): 132, 2023 09 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37666856
13.
A Next-Generation Sequencing Strategy for Evaluating the Most Common Genetic Abnormalities in Multiple Myeloma.
J Mol Diagn
; 19(1): 99-106, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27863261
14.
High FOXO3a expression is associated with a poorer prognosis in AML with normal cytogenetics.
Leuk Res
; 33(12): 1706-9, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19457552